Skip to main content
TipRanks
Go Ultimate75% OFF

Kontigo Care AB (3KT) AI Stock Analysis

0 Followers
DE:3KT

Kontigo Care AB

(Frankfurt:3KT)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Revenue ReaccelerationThe strong TTM revenue rebound signals improving demand and renewed commercial momentum. Sustained growth would expand the company’s monitored patient base and recurring service opportunity, while creating a larger platform from which operating leverage can develop over the next several quarters.
Negative Factors
Persistent Loss-Making ProfileOperating and net losses show that current revenue scale is still insufficient to cover the full cost base consistently. Until profitability becomes durable, Kontigo Care has less internally generated capacity for reinvestment and remains more exposed to setbacks in execution or demand.

Kontigo Care AB (3KT) vs. iShares MSCI Germany ETF (EWG)

-100%-75%-50%-25%0%25%50%DE:3KT-43.90%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 4.22M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-42.4
Beta (1Y)
0.86
Revenue Growth
4.45%
EPS Growth
39.53%
Country
Germany
Employees
11
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Kontigo Care AB Business Overview & Revenue Model

Company Description

Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Ga...

Kontigo Care AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:3KT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:QLIFESE:QLIFE67NeutralSEK 28.87M-0.741852.00%―142.55%73.84%
SE:PTRKSE:PTRK59NeutralSEK 180.49M-2.07――-10.30%-11.59%
SE:SEZISE:SEZI55NeutralSEK 551.04M-5.65-35.44%―18.56%28.11%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:MNTCSE:MNTC51NeutralSEK 455.64M-24.13-15.00%―11.18%60.51%
SE:AINOSE:AINO43NeutralSEK 40.10M-4.10133.94%―-10.72%-77.78%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:3KTSE:SEZISE:QLIFESE:AINOSE:MNTCSE:PTRKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:3KT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:3KTKontigo Care AB0.07-0.06-44.80%
SE:SEZISenzime AB3.50-1.75-33.24%
SE:QLIFEQlife Holding AB1.00-0.66-39.65%
SE:AINOAino Health AB0.200.0315.29%
SE:MNTCMentice AB16.202.3516.97%
SE:PTRKPhysitrack Limited11.10-4.00-26.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.